Live Yum Brands Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow IRIDEX CORP

Get SEC filing alerts via email and in your feed for IRIDEX CORP

IRIX

IRIDEX CORP

About IRIDEX CORP

IRIDEX Corporation develops ophthalmic laser systems utilizing proprietary MicroPulse and Endpoint Management technologies for the treatment of glaucoma and retinal diseases. Its product portfolio includes laser consoles, delivery devices, and single-use probes sold primarily to ophthalmologists and healthcare providers worldwide. The company emphasizes innovative, tissue-sparing laser therapies that improve clinical outcomes, safety, and efficiency in treating sight-threatening eye conditions across global markets.
This description was generated via AI from an annual report. Updated 10 months ago.

Latest SEC Filings from IRIDEX CORP

1
1
IRIDEX CORP IRIDEX Reports Slight Revenue Decline in Q1 Fiscal Year 2026

Via official filing (AI summary) | 2 months ago | 0 comments

2
1
IRIDEX CORP IRIDEX Corporation Reports 8.2% Revenue Growth to $52.7 Million, Net Loss Improves

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
IRIDEX CORP IRIDEX Corporation Reports 7.8% Revenue Growth in Q3 2025

Via official filing (AI summary) | 8 months ago | 0 comments

4
1
IRIDEX CORP IRIDEX Reports 7.4% Revenue Growth in Q2 2025, Net Loss Improves

Via official filing (AI summary) | 11 months ago | 0 comments

5
1
IRIDEX CORP IRIDEX Reports 1.1% Revenue Growth and Reduced Net Loss in Q1 FY 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
IRIDEX CORP IRIDEX Corporation Reports $48.7 Million Revenue and $8.9 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
IRIDEX CORP IRIDEX Corporation Reports Decline in Revenue and Profitability for Nine Months Ended September 28, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments